Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Idea Cellular IPO and SMS Pharmaceuticals IPO.
Idea Cellular IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while SMS Pharmaceuticals IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Citigroup Global Markets India Private Limited Bofa Securities India Limited Ubs Securities India Private Limited |
Uti Securities Ltd |
| Registrar | Bigshare Services Pvt Ltd | Aarthi Consultants Pvt Ltd. |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Idea Cellular IPO is up to ₹2,125.00 Cr whereas the issue size of the SMS Pharmaceuticals IPO is up to ₹97.93 Cr. The final issue price of Idea Cellular IPO is ₹75.00 per share and of SMS Pharmaceuticals IPO is ₹380.00 per share.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹360.00 per share |
| Issue Price (Upper) | ₹75.00 per share | ₹380.00 per share |
| Issue Price (Final) | ₹75.00 per share | ₹380.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 90 shares | 15 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 28,33,33,333 shares | 25,77,000 shares |
| Issue Size Total (Amount) | up to ₹2,125.00 Cr | up to ₹97.93 Cr |
Idea Cellular IPO opens on Feb 12, 2007, while SMS Pharmaceuticals IPO opens on Feb 05, 2007. The closing date of Idea Cellular IPO and SMS Pharmaceuticals IPO is Feb 15, 2007, and Feb 08, 2007, respectively.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 12, 2007 | Feb 05, 2007 |
| Issue Close | Feb 15, 2007 | Feb 08, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Idea Cellular IPO P/E ratio is , as compared to SMS Pharmaceuticals IPO P/E ratio of .
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 72.31% | |
| Promoter Shareholding (Post-Issue) | 53.68% | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 18.08%% | 17.41%% |
In the Idea Cellular IPO retail investors (RII) are offered while in SMS Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Idea Cellular IPO and in SMS Pharmaceuticals IPO.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Idea Cellular IPO subscribed 49.51x in total, whereas SMS Pharmaceuticals IPO subscribed 2.64x.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 78.68x | 3.47x |
| NII (times) | 22.82x | 0.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.87x | 2.47x |
| Employee (times) | 2.25x | |
| Other (times) | ||
| Total (times) | 49.51x | 2.64x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
